Effect of Unani Herbal decoction in Asthma
Phase 2
- Conditions
- Health Condition 1: J454- Moderate persistent asthma
- Registration Number
- CTRI/2020/03/024011
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient with symptoms of Wheeze, Cough with expectoration, Mild to moderate
Paroxysmal Dyspnoea
2.Mild to moderate asthma
3.Patients who have consented for the study
Exclusion Criteria
1.Patients below 18 and above 50 years of age
2.Acute or Severe Exacerbation(FEV1 or PEF < 40% predicted)
3.Patients with Systemic illnesses such as HTN, IHD, DM
4.Patients with a History of Allergic Rhinitis, COPD, Pneumonia, Occupational lung
diseases,Pulmonary tuberculosis
5.Pregnant and lactating women
6.Patients who had received corticosteroids, Bronchodilators or CAM therapy within
2weeks prior to enrolment
7.Patients who have not consented for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in FEV1, FEV1/FVC ratio, PEFTimepoint: 0th day and 45th day
- Secondary Outcome Measures
Name Time Method Improvement in ACT scoreTimepoint: 0th day, 15th day, 30th day and 45th day